131 related articles for article (PubMed ID: 15752746)
1. The substrate specificity of SARS coronavirus 3C-like proteinase.
Fan K; Ma L; Han X; Liang H; Wei P; Liu Y; Lai L
Biochem Biophys Res Commun; 2005 Apr; 329(3):934-40. PubMed ID: 15752746
[TBL] [Abstract][Full Text] [Related]
2. The N-terminal octapeptide acts as a dimerization inhibitor of SARS coronavirus 3C-like proteinase.
Wei P; Fan K; Chen H; Ma L; Huang C; Tan L; Xi D; Li C; Liu Y; Cao A; Lai L
Biochem Biophys Res Commun; 2006 Jan; 339(3):865-72. PubMed ID: 16329994
[TBL] [Abstract][Full Text] [Related]
3. Biosynthesis, purification, and substrate specificity of severe acute respiratory syndrome coronavirus 3C-like proteinase.
Fan K; Wei P; Feng Q; Chen S; Huang C; Ma L; Lai B; Pei J; Liu Y; Chen J; Lai L
J Biol Chem; 2004 Jan; 279(3):1637-42. PubMed ID: 14561748
[TBL] [Abstract][Full Text] [Related]
4. Virtual screening of novel noncovalent inhibitors for SARS-CoV 3C-like proteinase.
Liu Z; Huang C; Fan K; Wei P; Chen H; Liu S; Pei J; Shi L; Li B; Yang K; Liu Y; Lai L
J Chem Inf Model; 2005; 45(1):10-17. PubMed ID: 15667124
[TBL] [Abstract][Full Text] [Related]
5. 3C-like proteinase from SARS coronavirus catalyzes substrate hydrolysis by a general base mechanism.
Huang C; Wei P; Fan K; Liu Y; Lai L
Biochemistry; 2004 Apr; 43(15):4568-74. PubMed ID: 15078103
[TBL] [Abstract][Full Text] [Related]
6. A novel auto-cleavage assay for studying mutational effects on the active site of severe acute respiratory syndrome coronavirus 3C-like protease.
Shan YF; Li SF; Xu GJ
Biochem Biophys Res Commun; 2004 Nov; 324(2):579-83. PubMed ID: 15474466
[TBL] [Abstract][Full Text] [Related]
7. Quantitative Analysis of the Substrate Specificity of Human Rhinovirus 3C Protease and Exploration of Its Substrate Recognition Mechanisms.
Fan X; Li X; Zhou Y; Mei M; Liu P; Zhao J; Peng W; Jiang ZB; Yang S; Iverson BL; Zhang G; Yi L
ACS Chem Biol; 2020 Jan; 15(1):63-73. PubMed ID: 31613083
[TBL] [Abstract][Full Text] [Related]
8. Mining SARS-CoV protease cleavage data using non-orthogonal decision trees: a novel method for decisive template selection.
Yang ZR
Bioinformatics; 2005 Jun; 21(11):2644-50. PubMed ID: 15797903
[TBL] [Abstract][Full Text] [Related]
9. Study on substrate specificity at subsites for severe acute respiratory syndrome coronavirus 3CL protease.
Shan YF; Xu GJ
Acta Biochim Biophys Sin (Shanghai); 2005 Dec; 37(12):807-13. PubMed ID: 16331324
[TBL] [Abstract][Full Text] [Related]
10. A computational analysis of SARS cysteine proteinase-octapeptide substrate interaction: implication for structure and active site binding mechanism.
Phakthanakanok K; Ratanakhanokchai K; Kyu KL; Sompornpisut P; Watts A; Pinitglang S
BMC Bioinformatics; 2009 Jan; 10 Suppl 1(Suppl 1):S48. PubMed ID: 19208150
[TBL] [Abstract][Full Text] [Related]
11. Exploring the binding mechanism of the main proteinase in SARS-associated coronavirus and its implication to anti-SARS drug design.
Zhang XW; Yap YL
Bioorg Med Chem; 2004 May; 12(9):2219-23. PubMed ID: 15080921
[TBL] [Abstract][Full Text] [Related]
12. Dissection study on the severe acute respiratory syndrome 3C-like protease reveals the critical role of the extra domain in dimerization of the enzyme: defining the extra domain as a new target for design of highly specific protease inhibitors.
Shi J; Wei Z; Song J
J Biol Chem; 2004 Jun; 279(23):24765-73. PubMed ID: 15037623
[TBL] [Abstract][Full Text] [Related]
13. Biosynthesis, purification, and characterization of the human coronavirus 229E 3C-like proteinase.
Ziebuhr J; Heusipp G; Siddell SG
J Virol; 1997 May; 71(5):3992-7. PubMed ID: 9094676
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and evaluation of keto-glutamine analogues as potent inhibitors of severe acute respiratory syndrome 3CLpro.
Jain RP; Pettersson HI; Zhang J; Aull KD; Fortin PD; Huitema C; Eltis LD; Parrish JC; James MN; Wishart DS; Vederas JC
J Med Chem; 2004 Dec; 47(25):6113-6. PubMed ID: 15566280
[TBL] [Abstract][Full Text] [Related]
15. Hepatitis A virus 3C proteinase substrate specificity.
Jewell DA; Swietnicki W; Dunn BM; Malcolm BA
Biochemistry; 1992 Sep; 31(34):7862-9. PubMed ID: 1510973
[TBL] [Abstract][Full Text] [Related]
16. Mutational and inhibitive analysis of SARS coronavirus 3C-like protease by fluorescence resonance energy transfer-based assays.
Kuang WF; Chow LP; Wu MH; Hwang LH
Biochem Biophys Res Commun; 2005 Jun; 331(4):1554-9. PubMed ID: 15883050
[TBL] [Abstract][Full Text] [Related]
17. A consensus sequence for substrate hydrolysis by rhinovirus 3C proteinase.
Long AC; Orr DC; Cameron JM; Dunn BM; Kay J
FEBS Lett; 1989 Nov; 258(1):75-8. PubMed ID: 2556299
[TBL] [Abstract][Full Text] [Related]
18. Substrate specificity of the human coronavirus 229E 3C-like proteinase.
Ziebuhr J; Heusipp G; Seybert A; Siddell SG
Adv Exp Med Biol; 1998; 440():115-20. PubMed ID: 9782272
[TBL] [Abstract][Full Text] [Related]
19. Hydrolysis of a series of synthetic peptide substrates by the human rhinovirus 14 3C proteinase, cloned and expressed in Escherichia coli.
Orr DC; Long AC; Kay J; Dunn BM; Cameron JM
J Gen Virol; 1989 Nov; 70 ( Pt 11)():2931-42. PubMed ID: 2555433
[TBL] [Abstract][Full Text] [Related]
20. Mutational analysis of the active centre of coronavirus 3C-like proteases.
Hegyi A; Friebe A; Gorbalenya AE; Ziebuhr J
J Gen Virol; 2002 Mar; 83(Pt 3):581-593. PubMed ID: 11842253
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
